1-Bromo-2-Butyne CAS 3355-28-0 Maʻemaʻe ≥99.0% (GC) Linagliptin Intermediate Factory
Hāʻawi ka mea hana i ka Linagliptin a me nā mea pili e pili ana:
Linagliptin CAS 668270-12-0
Linagliptin Mākua Nucleus Intermediate CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
Inoa Kimia | 1-Bromo-2-Butyne |
Nā huaʻōlelo like | 2-Butynyl Bromide |
Helu CAS | 3355-28-0 |
Helu CAT | RF-PI500 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
ʻĀpana Molekala | C4H5Br |
Kaumaha Molecular | 132.99 |
Lae paila | 40.0~41.0℃/20 mmHg (māmā) |
ʻO ka mānoanoa | 1.519 g/ml ma 25 ℃ (māmā) |
Hōʻike Hōʻike | n20/D 1.508(māmā) |
Brand | ʻO Ruifu Chemical |
'ikamu | Nā kikoʻī |
Ka nana aku | ʻAʻohe wai melemele liʻiliʻi |
Maʻemaʻe / Kaʻina Hanana | ≥99.0% (GC) |
Māmā (KF) | ≤0.20% |
Koena ma ka Ignition | ≤0.10% |
Hoʻokahi haumia | ≤0.30% |
Huina paumaele | ≤1.0% |
ʻŌlelo | E ʻeleʻele ke kala ma hope o ka ʻike pinepine ʻana i ka ea |
E kūʻai ma kahi haʻahaʻa haʻahaʻa, ʻeleʻele, maloʻo a mālama ʻia ka nitrogen | |
E hoʻohana i ka hikiwawe ma hope o ka wehe ʻana | |
Kūlana hoʻāʻo | ʻOihana Kūlana |
Hoʻohana | Nā Kūwaena Lapaʻau |
Pūʻolo: ʻO ka ʻōmole, 25kg / Barrel a i ʻole 220kg pahu pahu, a i ʻole e like me ka koi o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.
Hoʻohana nui ʻia ka 1-Bromo-2-Butyne (CAS: 3355-28-0) i ka synthesis organik, synthesis o nā intermediates pharmaceutical a me Active Pharmaceutical Ingredient (API) synthesis.ʻO 1-Bromo-2-Butyne kahi mea koʻikoʻi koʻikoʻi i ka synthesis o Linagliptin (CAS: 668270-12-0) no ka mālama ʻana i nā pākeke me ka maʻi diabetes type 2.ʻO 1-Bromo-2-Butyne he mea kemika i hoʻohana ʻia i ka synthesis o nā pūhui teranyl axially chiral, alkylation o L-tryptophan methyl ester, 4-butynyloxybenzene sulfonyl chloride a me mono-propargylated diene derivative.Ma waho aʻe o kēia, hoʻohana ʻia i ka synthesis o isopropylbut-2-ynylamine, allenylcyclobutanol derivatives, allyl-[4- (akā-2-ynyloxy) phenyl] sulfane, allenylindium a me axially chiral teranyl pūhui.